BNR (BNR) Stock Price & Analysis
BNR (BNR) rose 11.22% to USD 11.99 as of September 8, 2026 at 06:23 UTC, according to Nexqual real-time market data.
BNR last closed at USD 11.99; the session ranged USD 10.16–12.05 on volume of 92,542 shares. Market capitalization is —, with a 52-week range of USD 6.79–41.72 (NGM). Source: Nexqual, September 8, 2026 at 06:23 UTC.
Key Statistics (as of September 8, 2026 at 06:23 UTC)
| Price | USD 11.99 |
|---|---|
| Change | ▲ 11.22% (up) |
| Previous Close | USD 11.99 |
| Open | USD 11.99 |
| Day Range | USD 10.16 – 12.05 |
| 52-Week Range | USD 6.79 – 41.72 |
| Volume | 92,542 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (BNR)
Nexqual's technical model rates BNR "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 06:23 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.56 (neutral) |
| vs SMA50 | Above (USD 9.66) |
| MACD | 0.27 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LEGN | Legend Biotech Corporation | USD 21.52 | ▼ 1.69% |
| NBP | NovaBridge Biosciences | USD 1.8 | ▲ 0.56% |
| NRIX | Nurix Therapeutics, Inc. | USD 26.14 | ▲ 1.24% |
| PRLD | Prelude Therapeutics Incorporat | USD 5.46 | ▲ 0.55% |
| PCVX | Vaxcyte, Inc. | USD 61.16 | ▼ 0.68% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:23 UTC. This page is informational and not investment advice.